miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer

• Omer Faruk Karatas,

  Affiliations Department of Medical Genetics, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey, Molecular Biology and Genetics Department, Erzurum Technical University, Erzurum, Turkey

  ⨯
• Esra Guzel,

  Affiliations Department of Medical Genetics, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey, Biruni University, Istanbul, Turkey

  ⨯
• Ilknur Suer,

  Affiliation Department of Medical Genetics, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey

  ⨯
• Isin D. Ekici,

  Affiliation Department of Medical Pathology, Yeditepe University, Istanbul, Turkey

  ⨯
• Turhan Caskurlu,

  Affiliation Departmentof Urology, Goztepe Education and Research Hospital, Goztepe, Istanbul, Turkey

  ⨯
• Chad J. Creighton,

  Affiliation Division of Biostatistics, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Michael Ittmann,

  Affiliation Department of Pathology & Immunology, Baylor College of Medicine, and Michael E. DeBakey VAMC, Houston, Texas, United States of America

  ⨯
• Mustafa Ozen

  * E-mail: mozen@bcm.edu

  Affiliations Department of Medical Genetics, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey, Biruni University, Istanbul, Turkey, Department of Pathology & Immunology, Baylor College of Medicine, and Michael E. DeBakey VAMC, Houston, Texas, United States of America

  ⨯